425: Arogo Capital Acquisition Corp. Faces Nasdaq Delisting Due to Non-Compliance with Listing Rules

Arogo Capital Acquisition Corp. is facing potential delisting from the Nasdaq due to non-compliance with several listing rules, including minimum market value, number of total holders, and publicly held shares.

Summary

• Arogo Capital Acquisition Corp. received a notice from Nasdaq on July 31, 2024, regarding non-compliance with listing rules.
• The company failed to maintain a Market Value of Listed Securities of at least $50 million (Nasdaq Listing Rule 5450(b)(2)(A)).
• The company did not have at least 400 total holders (Nasdaq Listing Rule 5450(a)(2)).
• The company did not have a minimum of 1,100,000 publicly held shares (Nasdaq Listing Rule 5450(b)(2)(B)).
• Arogo Capital requested a hearing before the Nasdaq Hearing Panel to request additional time to regain compliance and complete a business combination.
• The company is working to regain compliance, but there is no guarantee it will be successful.
• The company intends to file a registration statement on Form F-4, including a proxy statement/prospectus, with the SEC in connection with a proposed business combination transaction.
• The company's stockholders are advised to read the proxy statement/prospectus carefully when available.
• The document contains forward-looking statements regarding the company's ability to regain compliance with Nasdaq listing requirements and consummate the proposed business combination.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice and uncertainty surrounding the company's ability to regain compliance with Nasdaq listing requirements. The company is facing significant challenges and risks.

Positives

• The company is actively seeking to regain compliance with Nasdaq listing requirements by requesting a hearing.
• Arogo Capital is pursuing a business combination, which could potentially improve its financial position and compliance status.

Negatives

• Arogo Capital is currently non-compliant with multiple Nasdaq listing rules.
• There is no guarantee that the company will be able to regain compliance with Nasdaq's listing requirements.
• The company faces the risk of being delisted from the Nasdaq Global Market.

Risks

• The company's ability to regain compliance with Nasdaq listing requirements is uncertain.
• Failure to complete the proposed business combination could further jeopardize the company's compliance status.
• Delisting from Nasdaq could negatively impact the company's stock price and investor confidence.

Future Outlook

The company is focused on regaining compliance with Nasdaq listing requirements and completing a business combination, but there is no guarantee of success.

Management Comments

• The Company continues to work to regain compliance with Nasdaqs Listing Rules.
• There can be no assurance that the Company will be able to satisfy Nasdaqs continued listing requirements, regain compliance with Nasdaq Listing Rule 5450(b)(2)(A), Nasdaq Listing Rule 5450(a)(2), and Nasdaq Listing Rule 5450(b)(2)(B), or maintain compliance with other Nasdaq listing requirements.

Industry Context

SPACs (Special Purpose Acquisition Companies) like Arogo Capital have faced increased scrutiny and challenges in recent years, including difficulties in finding suitable merger targets and maintaining listing compliance.

Comparison to Industry Standards

• Many SPACs have struggled to maintain the minimum market capitalization required by exchanges like Nasdaq and NYSE.
• Some SPACs have been forced to liquidate and return capital to shareholders due to their inability to complete a business combination within the allotted timeframe.
• The performance of SPACs has generally lagged behind traditional IPOs in recent years.

Stakeholder Impact

• Shareholders face the risk of a decline in stock value and potential delisting.
• Employees may experience uncertainty regarding their job security.
• The proposed business combination partner, Ayurcann Holding Corp., is also affected by the uncertainty surrounding Arogo Capital's compliance status.

Next Steps

• The Company will participate in a hearing before the Nasdaq Hearing Panel.
• The Company intends to file a registration statement on Form F-4, which will include a proxy statement/prospectus, with the Securities and Exchange Commission (SEC).

Key Dates